The medical community highly recognizes NewEpi, with over 95% of medical centers adopting it.

We are thrilled to announce that JoyCom Group's exceptional product, NewEpi, has garnered high recognition within the medical community, with over 95% of medical centers choosing to use our product. This achievement is a testament to our continuous efforts and research, highlighting the outstanding quality and efficacy of NewEpi in the field of medicine.

NewEpi is an innovative medical product that has undergone extensive research and clinical trials. It promotes wound healing for various acute, chronic, and challenging wounds, improving patients' quality of life. JoyCom has been dedicated to providing high-quality pharmaceutical products and establishing close partnerships with healthcare institutions.

This milestone attests to the trust and reputation NewEpi has earned within the medical community. We are honored to offer effective clinical solutions to healthcare facilities and contribute to the health and medical well-being of patients. We will continue striving for excellence, constantly enhancing the quality and effectiveness of our products to meet the demand for high-quality products from healthcare professionals and patients.